WilliamsBGGouwsEBoschi-PintoCBryceJDyeC. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2002;2(1):25-32.
2.
McIntoshK. Community-acquired pneumonia in children. N Engl J Med. 2002;346:429-437.
3.
BartlettJG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis. 2011;52(suppl 4):S296-S304. doi:10.1093/cid/cir045.
JaffeACalderADOwensCMStanojevicSSonnappaS. Role of routine computed tomography in paediatric pleural empyema. Thorax. 2008;63:897-902. doi:10.1136/thx.2007.094250.
6.
KaplanSLMasonEOJrWaldER. Decrease of invasive pneumococcal infections in children among 8 children’s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004;113:443-449.
7.
LiSTTancrediDJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics. 2010;125:26-33. doi:10.1542/peds.2009-0184.
8.
GrijalvaCGNuortiJPZhuYGriffinMR. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis. 2010;50:805-813. doi:10.1086/650573.
9.
FinleyCCliftonJFitzgeraldJMYeeJ. Empyema: an increasing concern in Canada. Can Respir J. 2008;15:85-89.
10.
IslamSCalkinsCMGoldinAB. The diagnosis and management of empyema in children: a comprehensive review from the APSA outcomes and clinical trials committee. J Pediatr Surg. 2012;47:2101-2110. doi:10.1016/j.jpedsurg.2012.07.047
11.
AmaddeoATaddioAVenturaA. Hospitalizations after a decade of pneumococcal vaccination. N Engl J Med. 2013;369:1662. doi:10.1056/NEJMc1310477#SA2.
12.
NyambatBKilgorePEYongDE. Survey in childhood empyema in Asia: implications for detecting the unmeasured burden of culture negative bacterial disease. BMC Infect Dis. 2008;8:90. doi:10.1186/1471-2334-8-90.
13.
AvansinoJRGoldmanBSawinRSFlumDR. Primary operative versus nonoperative therapy for pediatric empyema: a meta-analysis. Pediatrics. 2005;115:1652-1659.
14.
BarnesTWOlsonEJMorgenthalerTIEdsonRSDeckerPARyuRH. Low yield of microbiologic studies on pleural fluid specimens. Chest. 2005;127:916-921.
15.
HendricksonDJBlumbergDAJoadJPJhawarSMcDonaldRJ. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2008;27:1030-1032. doi:10.1097/INF.0b013e31817e5188.
16.
ByingtonCLSpencerLYJohnsonTA. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34:434-440.
17.
Le MonnierACarbonnelleEZaharJR. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis. 2006;42:1135-1140.
18.
SaglaniSHarrisKAWallisCHartleyJC. Empyema: the use of broad range 16S rDNA PCR for pathogen detection. Arch Dis Child. 2005;90:70-73.
19.
EasthamKMFreemanRKearnsAM. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax. 2004;59:522-552.
20.
SchultzKDFanLLPinskyJ. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics. 2004;113:1735-1740.
21.
Balfour-LynnIMAbrahamsonECohenG. BTS guidelines for the management of pleural infection in children. Thorax. 2005;60(suppl 1):i1-i21.
22.
BradleyJSByingtonCLShahSS. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:617-630. doi:10.1093/cid/cir531.
23.
SpencerDAIqbalSMHasanAHamiltonL. Empyema thoracis is still increasing in UK children. BMJ. 2006;332(7553):1333.
24.
FletcherMASchmittHJSyrochkinaMSylvesterG. Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. Eur J Clin Microbiol Infect Dis. 2014;33:879-910. doi:10.1007/s10096-014-2062-6.
25.
BuckinghamSCKingMDMillerML. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J. 2003;22:499-504.
26.
PicazoJRuiz-ContrerasJCasado-FloresJ; HERACLES Study Group. Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain. Clin Vaccine Immunol. 2013;20:1524-1530. doi:10.1128/CVI.00239-13.
27.
LeeJHKimSHLeeJChoiEHLeeHJ. Diagnosis of pneumococcal empyema using immunochromatographic test on pleural fluid and serotype distribution in Korean children. Diagn Microbiol Infect Dis. 2012;72:119-124. doi:10.1016/j.diagmicrobio.2011.09.025.
BlaschkeAJHeyrendCByingtonCL. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J. 2011;30:289-294. doi:10.1097/INF.0b013e3182002d14.
30.
AmpofoKPaviaATChrisS. The changing epidemiology of invasive pneumococcal disease at a tertiary children’s hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J. 2012;31:228-234. doi:10.1097/INF.0b013e31823dcc72.
31.
TanTQMasonEOJrWaldER. Clinical characteristics of children with complicated pneumonia caused byStreptococcus pneumoniae. Pediatrics. 2002;110(1 pt 1):1-6.
32.
BenderJMAmpofoKKorgenskiK. Pneumococcal necrotizing pneumonia in Utah: does serotype matter?Clin Infect Dis. 2008;46:1346-1352. doi:10.1086/586747.
33.
ShenCFWangSMLeeKHHoTSLiuCC. Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan. J Formos Med Assoc. 2013;112:561-568. doi:10.1016/j.jfma.2013.05.015.
BaranwalAKSinghMMarwahaRKKumarL. Empyema thoracis: a 10-year comparative review of hospitalised children from south Asia. Arch Dis Child. 2003;88(11):1009-1014.
37.
LenKABergertLPatelSMelishMKimataCErdemG. Community-acquired staphylococcus aureus pneumonia among hospitalized children in Hawaii. Pediatr Pulmonol. 2010;45:898-905. doi:10.1002/ppul.21269.
38.
LangleyJMKellnerJDSolomonN. Empyema associated with community-acquired pneumonia: a pediatric investigator’s collaborative network on infections in Canada (PICNIC) study. BMC Infect Dis. 2008;8:129. doi:10.1186/1471-2334-8-129.
39.
CohenEMahantSDellSDTraubiciJ. The long-term outcomes of pediatric pleural empyema: a prospective study. Arch Pediatr Adolesc Med. 2012;166:999-1004. doi:10.1001/archpediatrics.2012.1055.
40.
GollompKRankinSCWhiteC. Broad-range bacterial polymerase chain reaction in the microbiologic diagnosis of complicated pneumonia. J Hosp Med. 2012;7(1):8-13. doi:10.1002/jhm.911.
ThomsonAHHullJKumarMRWallisCBalfour LynnIM. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax. 2002;57:343-347.
43.
RamirezSHildTGRudolphCN. Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a children’s hospital. Pediatrics. 2003;112:e380.
44.
SrinivasnakshatriVKSubramaniPVenkateshwaraprasadKNVarmaP. A fatal case of fungal empyema due to Candida krusei and Candida tropicalis: a rare occurrence with an atypical presentation. J Clin Diagn Res. 2014;8(11):DD01-2. doi:10.7860/JCDR/2014/10466.5205.
45.
KoSCChenKYHsuehPRLuhKTYangPC. Fungal empyema thoracis: an emerging clinical entity. Chest. 2000;117:1672-1678.
46.
IshiguroTTakayanagiNIkeyaT. Isolation of candida species is an important clue for suspecting gastrointestinal tract perforation as a cause of empyema. Intern Med. 2010;49:1957-1964.
47.
KingSThomsonA. Radiological perspectives in empyema. Br Med Bull. 2002;61:203-214.
48.
CalderAOwensCM. Imaging of parapneumonic pleural effusions and empyema in children. Pediatr Radiol. 2009;39:527-537.
49.
BalikMPlasilPWaldaufP. Ultrasound estimation of volume of pleural fluid in mechanically ventilated patients. Intensive Care Med. 2006;32:318-321.
50.
KurianJLevinTLHanBKTaraginBHWeinsteinS. Comparison of ultrasound and CT in the evaluation of pneumonia complicated by parapneumonic effusion in children. AJR Am J Roentgenol. 2009;193:1648-1654. doi:10.2214/AJR.09.2791.
51.
PillaiDSongXPastorW. Implementation and impact of a consensus diagnostic and management algorithm for complicated pneumonia in children. J Investig Med. 2011;59:1221-1227. doi:10.231/JIM.0b013e318231db4d.
52.
ShomakerKLWeinerTEstherCRJr.Impact of an evidence-based algorithm on quality of care in pediatric parapneumonic effusion and empyema. Pediatr Pulmonol. 2011;46:722-728. doi:10.1002/ppul.21429.
Centers for Disease Control and Prevention. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae—Massachusetts, 2001-2006. MMWR Morb Mortal Wkly Rep. 2007;56(41):1077-1080.
59.
LaiCYHuangLMLeePYLuCYShaoPLChangLY. Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease. J Microbiol Immunol Infect. 2014;47(1):23-27. doi:10.1016/j.jmii.2012.08.011.
60.
DaviesCHGleesonFVDaviesRJ. BTS guidelines on the management of pleural infection. Thorax. 2003;58(suppl 2):ii18-ii28.
61.
ShoseyovDBibiHShatzbergG. Short-term course and outcome of treatments of pleural empyema in pediatric patients: repeated ultrasound-guided needle thoracocentesis vs chest tube drainage. Chest. 2002;121:836-840.
62.
UyanAPOzyürekHYilmazE. Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children. Tuberk Toraks. 2003;51:320-324.
63.
KokoskaERChenMK, New Technology Committee. Position paper on video-assisted thoracoscopic surgery as treatment of pediatric empyema. J Pediatr Surg2009;44:289-293. doi:10.1016/j.jpedsurg.2008.08.037.
64.
KiliçNCelebiSGürpinarA. Management of thoracic empyema in children. Pediatr Surg Int. 2002;18:21-23.
65.
YaoCTWuJMLiuCCWuMHChuangHYWangJN. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children. Chest. 2004;125:566-571.
66.
CochranJBTecklenburgFWTurnerRB. Intrapleural instillation of fibrinolytic agents for treatment of pleural empyema. Pediatr Crit Care Med. 2003;4:39-43.
BourosDAntoniouKMChalkiadakisGDrositisJPetrakisISiafakasN. The role of video-assisted thoracoscopic surgery in the treatment of parapneumonic empyema after the failure of fibrinolytics. Surg Endosc. 2002;16:151-154.
69.
EkingenGGuvencBHSozubirSTuzlaciASenelU. Fibrinolytic treatment of complicated pediatric thoracic empyemas with intrapleural streptokinase. Eur J Cardiothorac Surg. 2004;26:503-507.
70.
BianchiniMACeccarelliPLRepettoP. Once-daily intrapleural urokinase treatment of complicated parapneumonic effusion in pediatric patients. Turk J Pediatr. 2010;52:274-277.
71.
YuH. Management of pleural effusion, empyema, and lung abscess. Semin Intervent Radiol. 2011;28(1):75-86. doi:10.1055/s-0031-1273942.
72.
KunamneniARavuriBDSaishaVEllaiahPPrabhakharT. Urokinase-a very popular cardiovascular agent. Recent Pat Cardiovasc Drug Discov. 2008;3(1):45-58.
73.
StefanuttiGGhirardoVBarbatoAGambaP. Evaluation of a pediatric protocol of intrapleural urokinase for pleural empyema: a prospective study. Surgery. 2010;148:589-594. doi:10.1016/j.surg.2010.01.010.
74.
MaskellNADaviesCWNunnAJ. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352:865-874.
WeinsteinMRestrepoRChaitPConnollyBTempleMMacarthurC. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions. Pediatrics. 2004;113:e182-e185.
77.
SimpsonGRoomesDHeronM. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest. 2000;117:1728-1733.
78.
LightRWNguyenTMulliganMESasseSA. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung. 2000;178:13-18.
79.
ZhuZHawthorneMLGuoY. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest. 2006;129:1577-1583.
80.
RahmanNMMaskellNAWestA. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518-526. doi:10.1056/NEJMoa1012740.
81.
BarbatoAPanizzoloCMonciottiCMarcucciFStefanuttiGGambaPG. Use of urokinase in childhood pleural empyema. Pediatr Pulmonol. 2003;35(1):50-55.
82.
WellsRHavensP. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology. 2003;228:370-378.
83.
CohenGHjortdalVRicciM. Primary thoracoscopic treatment of empyema in children. J Thorac Cardiovasc Surg. 2003;125:79-83.
84.
KalfaNAllalHMontes-TapiaF. Ideal timing of thoracoscopic decortication and drainage for empyema in children. Surg Endosc. 2004;18:472-477.
85.
SonappaSCohenGOwensCM. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med. 2006;174:221-227.
86.
St PeterSDTsaoKSpildeTL. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg. 2009;44(1):106-111. doi:10.1016/j.jpedsurg.2008.10.018.
87.
FaberDLBestLAOrlovskyMLapidotMNirRRKremerR. Streptokinase fibrinolysis protocol: the advantage of a non-operative treatment for stage II pediatric empyema patients. Isr Med Assoc J. 2012;14:157-161.
88.
CooteNKayE. Surgical versus non-surgical management of pleural empyema. Cochrane Database Syst Rev. 2005;(4):CD001956. Update in: Cochrane Database Syst Rev. 2009;(4):CD001956.
89.
ShahSSHallMNewlandJG. Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood. J Hosp Med. 2011;6:256-263. doi:10.1002/jhm.872.
90.
ChanPWCrawfordOWallisCDinwiddieR. Treatment of pleural empyema. J Paediatr Child Health. 2000;36:375-377.
